- Home
- EVR vs ITCI Comparison
EVR vs ITCI Comparison
Compare EVR & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVR
- ITCI
- Stock Information
- Founded
- EVR 1995
- ITCI 2002
- Country
- EVR United States
- ITCI United States
- Employees
- EVR N/A
- ITCI N/A
- Industry
- EVR Investment Managers
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- EVR Finance
- ITCI Health Care
- Exchange
- EVR Nasdaq
- ITCI Nasdaq
- Market Cap
- EVR 8.6B
- ITCI 8.0B
- IPO Year
- EVR 2006
- ITCI N/A
- Fundamental
- Price
- EVR $246.81
- ITCI $74.70
- Analyst Decision
- EVR Hold
- ITCI Strong Buy
- Analyst Count
- EVR 6
- ITCI 11
- Target Price
- EVR $250.00
- ITCI $97.00
- AVG Volume (30 Days)
- EVR 213.5K
- ITCI 456.3K
- Earning Date
- EVR 10-23-2024
- ITCI 10-31-2024
- Dividend Yield
- EVR 1.30%
- ITCI N/A
- EPS Growth
- EVR N/A
- ITCI N/A
- EPS
- EVR 7.24
- ITCI N/A
- Revenue
- EVR $2,624,426,000.00
- ITCI $564,526,000.00
- Revenue This Year
- EVR $22.47
- ITCI $46.60
- Revenue Next Year
- EVR $19.45
- ITCI $37.06
- P/E Ratio
- EVR $34.10
- ITCI N/A
- Revenue Growth
- EVR 5.83
- ITCI 54.31
- 52 Week Low
- EVR $124.53
- ITCI $45.50
- 52 Week High
- EVR $254.74
- ITCI $84.89
- Technical
- Relative Strength Index (RSI)
- EVR 59.89
- ITCI 50.77
- Support Level
- EVR $226.17
- ITCI $73.05
- Resistance Level
- EVR $241.69
- ITCI $76.98
- Average True Range (ATR)
- EVR 6.27
- ITCI 1.81
- MACD
- EVR 0.46
- ITCI 0.23
- Stochastic Oscillator
- EVR 79.42
- ITCI 56.41
About EVR Evercore Inc.
Evercore is an independent investment bank that derives the majority of its revenue from financial advisory, including merger, acquisition, and restructuring advisory. It also has institutional equities trading, equity underwriting, and investment management businesses that account for around 20% of net revenue. The company was founded in 1996 and went public in 2006. Evercore had approximately 2,200 employees at the end of 2023, and about 75% of its revenue is derived from the United States.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.